J. Scott International's Qualitative Detailing Analysis Reports.FORT WASHINGTON Fort Washington, military post during the American Revolution, situated on the highest point of Manhattan island, New York City, overlooking the Hudson River opposite Fort Lee, N.J. , Pa. -- Sanofi and Aventis Aventis Is a pharmaceutical and lab assay testing company. It was formed in 1999 when Rhône-Poulenc S.A. merged with Hoechst AG. The merged company was based in Strasbourg, France. Sanofi-Aventis was formed in 2004 when Sanofi-Synthélabo purchased Aventis. Detailing Forces Combined Rank #1 Overall in Physician Assessments; Top All Other Major Companies in Effectiveness and Value of Detail. Alcon Leads All Companies in Attribute Scoring. J. Scott International, Inc. (JSI JSI Japanese Society for Immunology (Tokyo, Japan) JSI Journal of School Improvement JSI Jantzi Social Index (Michael Jantzi Research Associates) JSI Journal of Social Issues ), a leading strategic healthcare research firm, reports that joining year-to-date Year-to-date (YTD) The period beginning at the start of the calendar year up to the current date. data for the respective Sanofi and Aventis detailing forces results in the combined company placing first among major companies in MD appraisal of detailing efforts over the January January: see month. to September September: see month. , 2004 period. JSI's Qualitative Detailing Analysis (QDA QDA Quantity Discount Agreement QDA Quantitative Data Analysis QDA Quick Defect Analysis QDA Quadratic Discriminate Analysis QDA Qualitative Data Analysis ) uniquely examines the strength of a pharmaceutical representative's relationship with the physician, the physician's view of the representative's attributes, the doctor's assessment of the detailing presentation -- its objectives, believability be·liev·a·ble adj. Capable of eliciting belief or trust. See Synonyms at plausible. be·liev  a·bil , effectiveness and value. Information
is also provided by the physician as to how the detail could have been
more effective, and more informative.QDA recorded details from 235 companies for the first 9 months of the year; the top 20 companies in detailing volume account for 75% of all details reported. Shown below are the individual performance ratings See benchmark. of the top 10 ranked companies within the group of 20, the results of physician assessment of the detailing presentation in general and within 4 major elements. Sanofi-Aventis Sanofi-Aventis (Euronext: SAN, NYSE: SNY), headquartered in Paris, France, is one of the five largest pharmaceutical companies in the world, along with Pfizer, Bristol-Myers Squibb, Novartis, and GlaxoSmithKline. occupies the top rank overall, and in Effectiveness of Detail, and Value of Detail. The company places second in Believability of Presentation and Persuasiveness per·sua·sive adj. Tending or having the power to persuade: a persuasive argument. per·sua of Representative. Ranking #1 in Believability is TAP while Alcon occupies the top position in Persuasiveness. Shown below are the individual performance ratings of the top 10 ranked companies.
Believability Persuasiveness
Overall of of
Company Rating Presentation Representative
---------------------------- ----------- ------------- ---------------
Sanofi-Aventis 1 2 2
Ortho-McNeil Pharmaceutical 2 3 4
Pfizer 3 6 3
TAP 4 1 8
Boehringer-Ingelheim 5 7 5
Alcon 6 4 1
Forest 7 10 11
Novartis 8 5 6
GlaxoSmithKline 9 8 9
AstraZeneca 10 9 12
Effectiveness of
Company Detail Value of Detail
---------------------------- -------------------- --------------------
Sanofi-Aventis 1 1
Ortho-McNeil Pharmaceutical 2 4
Pfizer 3 6
TAP 9 3
Boehringer-Ingelheim 8 2
Alcon 6 16
Forest 4 5
Novartis 5 9
GlaxoSmithKline 7 10
AstraZeneca 12 7
A segmenting of the data shows differences dependent upon physician type. (QDA covers 26 specialties.) As an example, in viewing just the Primary Care physician group, Merck Merck may refer to:
People with the surname Janssen:
The QDA's measurement of physician perception of representatives' attributes provides insight into the quality and strength of the MD-representative relationship, and offers a different gauge for evaluating the impact of the representative. These assessments are of the detailer rather than the detail. The following illustrates the top 10 companies in attribute rankings based upon the percentage of QDA physicians responding positively to the statement.
Look
Total of Rated Forward
Attributes Top to Articulates
Company Ratings Tier Seeing Information
---------------------------- ---------- ------- --------- ------------
Alcon 1 2 1 1
Berlex 2 3 2 3
Ortho-McNeil Pharmaceuticals 3 1 15 4
Novartis 4 7 5 6
Pfizer 5 4 3 7
Sanofi-Aventis 6 5 6 10
GlaxoSmithKline 7 8 11 11
Eli Lilly 8 10 13 5
Allergan 9 6 4 8
TAP 10 11 8 13
Services Asks
Effective Use Practice Meaningful
Company of Time Needs Questions
----------------------------- ------------- ------------- ------------
Alcon 1 1 1
Berlex 2 4 6
Ortho-McNeil Pharmaceuticals 5 2 5
Novartis 3 3 2
Pfizer 7 6 7
Sanofi-Aventis 9 12 9
GlaxoSmithKline 4 5 10
Eli Lilly 13 9 3
Allergan 17 11 17
TAP 8 7 12
Alcon places first in all attributes but one; Ortho-McNeil places first in percentage of physicians rating their reps as "Top Tier". Note that another specialty company - Allergan - ranks among the top 10 here. QDA covers a myriad Myriad is a classical Greek name for the number 104 = 10 000. In modern English the word refers to an unspecified large quantity. The term myriad is a progression in the commonly used system of describing numbers using tens and hundreds. of other qualitative and quantitative assessments of the detailing process, as well as providing information to be used in tandem Adv. 1. in tandem - one behind the other; "ride tandem on a bicycle built for two"; "riding horses down the path in tandem" tandem with JSI's "Longitudinal lon·gi·tu·di·nal adj. Running in the direction of the long axis of the body or any of its parts. Analysis - Patient Dialogue" Study for further examination of the rep-to-doctor-to-patient, patient-to-doctor, and pharmaceutical company-to-patient information sequence. For further information on QDA, or other JSI services, or to request an on-site presentation, please contact: Michael J. DeCrescio Chief Operating Officer 215-358-0800 mdecrescio@jscott-intl.com Or Stephen C. Chappell Senior VP 215-358-0800 schappell@jscott-intl.com |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion